Literature DB >> 29847481

Cardiovascular Risk Profile of Transgender Women With HIV: A US Health Care Database Study.

Shawnbir Gogia1, Alexandra Coromilas1, Susan Regan2, Lauren Stone3, Lindsay T Fourman3, Virginia A Triant2,4, Tomas G Neilan5,6, Markella V Zanni3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29847481      PMCID： PMC6092224          DOI： 10.1097/QAI.0000000000001767

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  18 in total

1.  Medication adherence among transgender women living with HIV.

Authors:  Glenda N Baguso; Caryl L Gay; Kathryn A Lee
Journal:  AIDS Care       Date:  2016-02-24

Review 2.  Is anemia a new cardiovascular risk factor?

Authors:  Georgia Kaiafa; Ilias Kanellos; Christos Savopoulos; Nikolaos Kakaletsis; George Giannakoulas; Apostolos I Hatzitolios
Journal:  Int J Cardiol       Date:  2015-03-17       Impact factor: 4.164

3.  Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania.

Authors:  Megan E O'Brien; Roland Kupka; Gernard I Msamanga; Elmar Saathoff; David J Hunter; Wafaie W Fawzi
Journal:  J Acquir Immune Defic Syndr       Date:  2005-10-01       Impact factor: 3.731

Review 4.  Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern.

Authors:  Louis J Gooren; Katrien Wierckx; Erik J Giltay
Journal:  Eur J Endocrinol       Date:  2014-03-10       Impact factor: 6.664

5.  Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study.

Authors:  K Wierckx; E Elaut; E Declercq; G Heylens; G De Cuypere; Y Taes; J M Kaufman; G T'Sjoen
Journal:  Eur J Endocrinol       Date:  2013-09-13       Impact factor: 6.664

6.  Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.

Authors:  Matthew S Freiberg; Chung-Chou H Chang; Melissa Skanderson; Olga V Patterson; Scott L DuVall; Cynthia A Brandt; Kaku A So-Armah; Ramachandran S Vasan; Kris Ann Oursler; John Gottdiener; Stephen Gottlieb; David Leaf; Maria Rodriguez-Barradas; Russell P Tracy; Cynthia L Gibert; David Rimland; Roger J Bedimo; Sheldon T Brown; Matthew Bidwell Goetz; Alberta Warner; Kristina Crothers; Hilary A Tindle; Charles Alcorn; Justin M Bachmann; Amy C Justice; Adeel A Butt
Journal:  JAMA Cardiol       Date:  2017-05-01       Impact factor: 14.676

7.  Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system.

Authors:  Virginia A Triant; Susan Regan; Hang Lee; Paul E Sax; James B Meigs; Steven K Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

8.  HIV infection and the risk of acute myocardial infarction.

Authors:  Matthew S Freiberg; Chung-Chou H Chang; Lewis H Kuller; Melissa Skanderson; Elliott Lowy; Kevin L Kraemer; Adeel A Butt; Matthew Bidwell Goetz; David Leaf; Kris Ann Oursler; David Rimland; Maria Rodriguez Barradas; Sheldon Brown; Cynthia Gibert; Kathy McGinnis; Kristina Crothers; Jason Sico; Heidi Crane; Alberta Warner; Stephen Gottlieb; John Gottdiener; Russell P Tracy; Matthew Budoff; Courtney Watson; Kaku A Armah; Donna Doebler; Kendall Bryant; Amy C Justice
Journal:  JAMA Intern Med       Date:  2013-04-22       Impact factor: 21.873

Review 9.  Pathophysiology and management of cardiovascular disease in patients with HIV.

Authors:  Eric Nou; Janet Lo; Colleen Hadigan; Steven K Grinspoon
Journal:  Lancet Diabetes Endocrinol       Date:  2016-02-10       Impact factor: 32.069

10.  Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease.

Authors:  Álvaro H Borges; Jeffrey I Weitz; Gary Collins; Jason V Baker; Yves Lévy; Richard T Davey; Andrew N Phillips; James D Neaton; Jens D Lundgren; Steven G Deeks
Journal:  AIDS       Date:  2014-07-31       Impact factor: 4.177
View more
  4 in total

1.  Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.

Authors:  Laura M Smeaton; Emma M Kileel; Beatriz Grinsztejn; Edward M Gardner; Kate Starr; Melissa L Murry; Patrice Desvigne-Nickens; Beverly Alston-Smith; Myron A Waclawiw; Katharine Cooper-Arnold; José V Madruga; Shashi Sangle; Kathleen V Fitch; Markella V Zanni; Pamela S Douglas; Heather J Ribaudo; Steven K Grinspoon; Karin L Klingman
Journal:  J Infect Dis       Date:  2020-07-09       Impact factor: 5.226

Review 2.  Cardiovascular Disease Risk Among Transgender People with HIV.

Authors:  Madeline Cetlin; Evelynne S Fulda; Sarah M Chu; Ole-Petter R Hamnvik; Tonia Poteat; Markella V Zanni; Mabel Toribio
Journal:  Curr HIV/AIDS Rep       Date:  2021-10-09       Impact factor: 5.071

3.  Cardiovascular disease risk among transgender women living with HIV in the United States.

Authors:  Bennett J Gosiker; Catherine R Lesko; Ashleigh J Rich; Heidi M Crane; Mari M Kitahata; Sari L Reisner; Kenneth H Mayer; Rob J Fredericksen; Geetanjali Chander; William C Mathews; Tonia C Poteat
Journal:  PLoS One       Date:  2020-07-20       Impact factor: 3.240

Review 4.  Cardiovascular disease in transgendered people: A review of the literature and discussion of risk.

Authors:  Leighton J Seal
Journal:  JRSM Cardiovasc Dis       Date:  2019-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.